Aeras Global TB Vaccine Foundation Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
1
- Exits
-
2

Aeras Global TB Vaccine Foundation General Information
Company Description
Founded in 2003, Aeras Global TB Vaccine Foundation was a non-profit venture capital investment firm based in Rockville, Maryland. The firm was a Provider of research and development services.
Business Details
Website
www.aeras.orgYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 1405 Research Boulevard
- Rockville, MD
- United States
Aeras Global TB Vaccine Foundation Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Oxford-Emergent Tuberculosis Consortium | Pharmaceuticals | Out of Business |
Aeras Global TB Vaccine Foundation Exits (2)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) | 23-Jun-2015 | Merger/Acquisition | |
Oxford-Emergent Tuberculosis Consortium | 06-Jun-2013 |
Aeras Global TB Vaccine Foundation Investments by Industry, Year, and Region
Aeras Global TB Vaccine Foundation FAQs
-
What is Aeras Global TB Vaccine Foundation?
Founded in 2003, Aeras Global TB Vaccine Foundation was a non-profit venture capital investment firm based in Rockville, Maryland.
-
When was Aeras Global TB Vaccine Foundation founded?
Aeras Global TB Vaccine Foundation was founded in 2003.
-
Where is Aeras Global TB Vaccine Foundation headquartered?
Aeras Global TB Vaccine Foundation is headquartered in Rockville, MD.
-
How many investments has Aeras Global TB Vaccine Foundation made?
Aeras Global TB Vaccine Foundation has made 1 investments.
-
What has Aeras Global TB Vaccine Foundation invested in?
Aeras Global TB Vaccine Foundation has invested in Oxford-Emergent Tuberculosis Consortium within the Pharmaceuticals industry.
-
What has Aeras Global TB Vaccine Foundation invested in recently?
Aeras Global TB Vaccine Foundation's latest investment was on
in Oxford-Emergent Tuberculosis Consortium, a company within the Pharmaceuticals industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »